Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves
- PMID: 35476709
- PMCID: PMC9045619
- DOI: 10.1371/journal.pone.0263316
Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves
Abstract
This study determined the presence of anti-SARS-CoV-2 antibodies in 4964 individuals, comprising 300 coronavirus disease-19 (COVID-19) prepandemic serum samples, 142 COVID-19 patients, 2113 individuals at risk due to their occupations, 1856 individuals at risk due to sharing workplaces or communities with COVID-19 patients, and 553 Thai citizens returning after spending extended periods of time in countries with a high disease prevalence. We recruited participants between May 2020 and May 2021, which spanned the first two epidemic waves and part of the third wave of the COVID-19 outbreaks in Thailand. Their sera were tested in a microneutralization and a chemiluminescence immunoassay for IgG against the N protein. Furthermore, we performed an immunofluorescence assay to resolve discordant results between the two assays. None of the prepandemic sera contained anti-SARS-CoV-2 antibodies, while antibodies developed in 88% (15 of 17) of the COVID-19 patients at 8-14 days and in 94-100% of the patients between 15 and 60 days after disease onset. Neutralizing antibodies persisted for at least 8 months, longer than IgG antibodies. Of the 2113 individuals at risk due to their occupation, none of the health providers, airport officers, or public transport drivers were seropositive, while antibodies were present in 0.44% of entertainment workers. Among the 1856 individuals at risk due to sharing workplaces or communities with COVID-19 patients, seropositivity was present in 1.9, 1.5, and 7.5% of the Bangkok residents during the three epidemic waves, respectively, and in 1.3% of the Chiang Mai people during the first epidemic wave. The antibody prevalence varied between 6.5 and 47.0% in 553 Thai people returning from high-risk countries. This serosurveillance study found a low infection rate of SARS-CoV-2 in Thailand before the emergence of the Delta variant in late May 2021. The findings support the Ministry of Public Health's data, which are based on numbers of patients and contact tracing.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand.BMC Infect Dis. 2021 Dec 6;21(1):1213. doi: 10.1186/s12879-021-06921-y. BMC Infect Dis. 2021. PMID: 34872510 Free PMC article.
-
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.Sci Rep. 2023 Sep 20;13(1):15595. doi: 10.1038/s41598-023-42754-2. Sci Rep. 2023. PMID: 37730917 Free PMC article.
-
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.Clin Microbiol Infect. 2021 Apr;27(4):633.e1-633.e7. doi: 10.1016/j.cmi.2020.11.013. Epub 2020 Nov 28. Clin Microbiol Infect. 2021. PMID: 33253941 Free PMC article.
-
Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 among at-risk populations in Chiang Mai and Lamphun provinces, Thailand, during November 2020-January 2021.PLoS One. 2022 Feb 2;17(2):e0263127. doi: 10.1371/journal.pone.0263127. eCollection 2022. PLoS One. 2022. PMID: 35108302 Free PMC article.
-
Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis.Int J Infect Dis. 2023 Sep;134:160-167. doi: 10.1016/j.ijid.2023.06.009. Epub 2023 Jun 15. Int J Infect Dis. 2023. PMID: 37327857 Free PMC article.
Cited by
-
SARS-CoV-2 seroprevalence among cancer patients and household caregivers in a cancer hospital: Cross-sectional survey after the second COVID-19 wave in Thailand.Public Health Pract (Oxf). 2022 Dec;4:100341. doi: 10.1016/j.puhip.2022.100341. Epub 2022 Nov 6. Public Health Pract (Oxf). 2022. PMID: 36373034 Free PMC article.
-
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023.Nat Commun. 2024 Jul 11;15(1):5847. doi: 10.1038/s41467-024-50052-2. Nat Commun. 2024. PMID: 38992013 Free PMC article.
-
Seroprevalence of SARS-CoV-2 nucleocapsid antibody among sex workers during the 5th epidemic wave with Omicron variant in Chiang Mai, Thailand.Heliyon. 2024 Aug 23;10(17):e36807. doi: 10.1016/j.heliyon.2024.e36807. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263051 Free PMC article.
-
Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients.PLoS One. 2024 Apr 16;19(4):e0298033. doi: 10.1371/journal.pone.0298033. eCollection 2024. PLoS One. 2024. PMID: 38626137 Free PMC article.
-
A Novel Simian Adenovirus Associating with Human Adeno-virus Species G Isolated from Long-Tailed Macaque Feces.Viruses. 2023 Jun 14;15(6):1371. doi: 10.3390/v15061371. Viruses. 2023. PMID: 37376670 Free PMC article.
References
-
- Sirilak S, editor. Thailand’s experience in the COVID-19 response [Internet]. Ministry of Public Health, Thailand. Aug 2020. [Cited 2021 October 31]. Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/pubdoc/LDoc9.pdf.
-
- Cheepsattayakorn A, Cheepsattayakorn R, Siriwanarangsun P. New waves of COVID-19 in Thailand, Cambodia and Myanmar. Am J Intern Med. 2021;9:114–20.
-
- WHO Cambodia. Cambodia Coronavirus Disease 2019 (COVID-19) Situation Report #35. 2021 March 01 [Cited 2021 October 31]. Available from: https://www.who.int/cambodia/internal-publications-detail/covid-19-joint....
-
- Tribune B. First local cases of contagious Indian variant discovered among construction workers in Lak Si. Bangkok Tribune Online News Agency. 2021. May 21 [Cited 2021 October 31]. Available from: https://bkktribune.com/first-local-cases-of-contagious-indian-variant-di....
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous